The importance of patient support

The importance of adherence

Ensuring that patients take their medications as prescribed is a key to successful therapy. However, it has also been recognized as a growing challenge in health care systems worldwide.

Non-adherence and poor compliance can have serious impact on health, as patients do not receive optimal therapy for their condition. Poor adherence is often associated with increased healthcare use, morbidity, and mortality. It also causes additional costs due to waste of medicines, manpower/man-days and time.

Patients’ non-adherence to medications costs EU governments an estimated €125 billion annually. It contributes to premature deaths of nearly 200,000 European citizens a year:

  • Approximately 20% to 50% of patients do not adhere to the prescribed medical therapy
  • It is estimated that 2 0% – 30% of patients do not adhere to the prescribed regimens which are curative or intended to relieve symptoms
  • 30% – 40% fail to follow the recommended preventive regimens

Adherence in long-term medication regimens

The numbers for long-term medication regimens are even more dramatic. The World Health Organization (WHO) report reveals that when the long-term therapy is prescribed, approximately 50% of patients fail to adhere to the regimen. The main reasons for not taking medication are:

  • Forgetfulness (71%)
  • Lack of belief that the medication was needed (20%)
  • The belief that the condition has improved and that the medication is not needed (16%)

Why do patients fail to adhere to the regimen?

WHO’s multidimensional model defines adherence as a multidimensional phenomenon determined by the relationship of five factors: socio-economic, healthcare system, condition, treatment, and patient-related factors.

The reasons for non-adherence may also be divided into non-intentional (patients forget to take their therapy or do not understand the regimen) and intentional (try to reduce costs, do not think that the medication is needed, they are worried about side effects). The non-intentional non-adherence is easier to address through patient reminders, while intentional non-adherence requires different strategies.

The importance of patient support

Although the factors which may contribute to non-adherence are complex and challenging to address, including forgetfulness, confusion due to a complex treatment regimen, struggle with self-administration, side effects, no perceived benefit etc., it is of the utmost importance that all the stakeholders gather in the effort of encouraging the patients to adhere to their therapies and to achieve health outcomes that are as good as possible.

This is particularly critical in countries of lower GDP with more challenging access to expensive medication. The collaboration includes policy makers (Ministry of Health, health insurance funds), healthcare professionals, pharmaceutical companies, patients and their associations, families/caregivers and the media.

Our patient support programs

Weare proud to be among the pioneers in Croatia to develop tailor-made patient support programs (PSPs) for various needs of different groups of patients, therapies and healthcare systems.

PSPs are designed to use multiple methods of interaction and multiple communication channels to assist in improving compliance to therapy.

A strategy to create and deploy incentives for health professionals and patients to integrate therapy adherence in treatment plans, focusing on quality instead of the volume of care services:

  • Increases therapy adherence
  • Helps dismantle barriers
  • Streamlines the adoption of practices

The regulation of PSP

Our activities in the field of PSP are compliant with all applicable laws and regulations.

We see each PSP as a tailor-made program which helps the patients in managing their disease(s) in a better way. Each patient is unique, and so is each medicinal product and medical device. We in Marti Farm recognize the particular needs of patients, the industry and payers, and work together with our partners for the benefit of all.

Contact us

Headquarters

Lašćinska cesta 40
HR-10000 Zagreb
Croatia

Office

Planinska ulica 13/2
HR-10000 Zagreb
Croatia

Office: +385 1 5588 297
Pharmacovigilance: +385 1 5588 297
Clinical trials: +385 1 5614 330
Registration: +385 1 242 0873
Marketing: +385 1 2420 890
Fax: +385 1 2420 860
info@martifarm.com

Pharmacovigilance

farmakovigilancija@martifarm.com
Tel: +385 1 5588 297

Data usage consent:

13 + 1 =

Data usage consent:

5 + 7 =

Legal info

Full company name
Short company name
Headquarters
Office
Legal form
Court register
Registration number

Marti Farm Ltd. Trade and Services
Marti Farm Ltd.
Lašćinska cesta 40, HR-10000 Zagreb
Planinska ulica 13/2, HR-10000 Zagreb
a limited liability company
Commercial Court of Zagreb
080751121

 

OIB
Share capital
Authorized representative

29969122438
HRK 20,000.00 (paid in its entirety)
Martina Diminić Smetiško, director of the
company (Representing the company
individually and independently, Responsible
person for data protection)

 

Bank account

HR3623600001102197724 (Zagrebačka banka)
HR4324020061100628669 (Erste banka)

 

Full company name: Marti Farm Ltd. Trade and Services
Short company name: Marti Farm Ltd.
Headquarters: Lašćinska cesta 40, HR-10000 Zagreb
Office: Planinska ulica 13/2, HR-10000 Zagreb
Legal form: a limited liability company
Court register: Commercial Court of Zagreb
Registration number: 080751121

OIB: 29969122438
Share capital: HRK 20,000.00 (paid in its entirety)
Authorized representative: Martina Diminić Smetiško, director of the company (Representing the company individually and independently, Responsible person for data protection)

Bank account: HR3623600001102197724 (Zagrebačka banka), HR4324020061100628669 (Erste banka)

All rights reserved Marti Farm ltd 2018. | Terms of Use | Privacy Policy

Share This

Share this post with your friends!